Guardant Health Eclipse Study

Listing Websites about Guardant Health Eclipse Study

Filter Type:

A Cell-free DNA Blood-Based Test for Colorectal Cancer Screening

(1 days ago) WebThe ECLIPSE (Evaluation of the ctDNA LUNAR Test in an Average Patient Screening Episode) study was designed to evaluate the performance of the cfDNA …

https://www.nejm.org/doi/full/10.1056/NEJMoa2304714

Category:  Health Show Health

Guardant Health announces positive results from pivotal ECLIPSE …

(7 days ago) WebECLIPSE is a prospective registrational study to evaluate the performance of Guardant Health’s blood test in detecting signs of CRC compared to a screening …

https://investors.guardanthealth.com/press-releases/press-releases/2022/Guardant-Health-announces-positive-results-from-pivotal-ECLIPSE-study-evaluating-a-blood-test-for-the-detection-of-colorectal-cancer/default.aspx

Category:  Health Show Health

Clinical Studies - GuardantHealth

(4 days ago) WebThe ECLIPSE study is a prospective registrational study to evaluate the performance of Guardant Health’s blood test in detecting signs of colorectal cancer compared to a …

https://guardanthealth.com/clinical-studies/

Category:  Cancer Show Health

Guardant Health, Inc. - Guardant Health ECLIPSE Study Data

(6 days ago) WebStudy shows blood-based cancer screening test detects 83% of people with colorectal cancer with specificity of 90% Results pave the way for first potential FDA …

https://investors.guardanthealth.com/press-releases/press-releases/2024/Guardant-Health-ECLIPSE-Study-Data-Demonstrating-Efficacy-of-Shield-Blood-based-Test-for-Colorectal-Cancer-Screening-to-be-Published-in-The-New-England-Journal-of-Medicine/default.aspx

Category:  Cancer Show Health

Guardant Health, Inc. - Guardant Health Initiates …

(1 days ago) WebProspective Study Expected to Enroll 10,000 Average-Risk Patients to Assess Performance of Blood Test for Early Detection of Colorectal Cancer President & COO Chief Executive Officer Guardant …

https://investors.guardanthealth.com/press-releases/press-releases/2019/Guardant-Health-Initiates-ECLIPSE-Pivotal-Study-for-its-LUNAR-2-Blood-Test-for-Colorectal-Cancer-Screening/default.aspx

Category:  Cancer Show Health

Guardant Health presents additional information from ECLIPSE …

(2 days ago) WebPALO ALTO, Calif.--(BUSINESS WIRE)-- Guardant Health, Inc. (Nasdaq: GH), a leading precision oncology company, today presented additional data from the …

https://investors.guardanthealth.com/press-releases/press-releases/2023/Guardant-Health-presents-additional-information-from-ECLIPSE-study-at-2023-Digestive-Disease-Week-on-the-performance-of-Shield-blood-test/default.aspx

Category:  Health Show Health

Guardant Health ECLIPSE Study Data Demonstrating Efficacy of …

(Just Now) WebECLIPSE is a prospective registrational study to evaluate the performance of Guardant Health’s blood test in detecting signs of CRC compared to a screening …

https://finance.yahoo.com/news/guardant-health-eclipse-study-data-210000399.html

Category:  Health Show Health

Guardant Health announces positive results from pivotal ECLIPSE …

(9 days ago) WebECLIPSE is a prospective registrational study to evaluate the performance of Guardant Health’s blood test in detecting signs of CRC compared to a screening …

https://www.businesswire.com/news/home/20221215006055/en/Guardant-Health-announces-positive-results-from-pivotal-ECLIPSE-study-evaluating-a-blood-test-for-the-detection-of-colorectal-cancer

Category:  Health Show Health

Guardant Health Announces ECLIPSE Study Update Call on May 9, …

(Just Now) WebGuardant Health, Inc. (Nasdaq: GH), a leading precision oncology company, today announced it will report additional data from its pivotal ECLIPSE study at …

https://investors.guardanthealth.com/press-releases/press-releases/2023/Guardant-Health-Announces-ECLIPSE-Study-Update-Call-on-May-9-2023/default.aspx

Category:  Health Show Health

Guardant Health Initiates ECLIPSE Pivotal Study for its LUNAR-2 …

(2 days ago) WebGuardant Health, Inc. has initiated the ECLIPSE trial, a 10,000-patient registrational study to evaluate the performance of its LUNAR-2 blood test to detect colorectal cancer (CRC) …

https://www.guardanthealthamea.com/guardant-health-initiates-eclipse-pivotal-study-for-its-lunar-2-blood-test-for-colorectal-cancer-screening/

Category:  Cancer Show Health

Guardant Health Reaches Target Enrollment of 12,750 Patients in …

(4 days ago) WebTopline Data Release from ECLIPSE Planned for Mid-2022 Subject to Positive Study Outcome, Data Will Support a Premarket Approval (PMA) Submission to …

https://investors.guardanthealth.com/press-releases/press-releases/2021/Guardant-Health-Reaches-Target-Enrollment-of-12750-Patients-in-ECLIPSE-Pivotal-Study-for-its-LUNAR-2-Blood-Test-to-Detect-Colorectal-Cancer/default.aspx

Category:  Health Show Health

Guardant Health Announces ECLIPSE Study Update Call on May 9, …

(7 days ago) WebGuardant Health, Inc. (Nasdaq: GH), a leading precision oncology company, today announced it will report additional data from its pivotal ECLIPSE stud Guardant …

https://www.businesswire.com/news/home/20230504006138/en/

Category:  Health Show Health

Guardant Health, Inc. - Guardant Health -ECLIPSE Study Results

(3 days ago) WebGuardant Health -ECLIPSE Study Results. December 15, 2022. At Guardant Health Inc., we promise to treat your data with respect and will not share your …

https://investors.guardanthealth.com/events-and-presentations/presentations/presentation-details/2022/Guardant-Health--ECLIPSE-Study-Results/default.aspx

Category:  Health Show Health

Guardant Health Announces ECLIPSE Study Update Call on May 9, …

(5 days ago) WebPALO ALTO, Calif., May 05, 2023--Guardant Health, Inc. (Nasdaq: GH), a leading precision oncology company, today announced it will report additional data from its pivotal …

https://finance.yahoo.com/news/guardant-health-announces-eclipse-study-120000559.html

Category:  Health Show Health

Guardant Health ECLIPSE Study Data Demonstrating Efficacy of …

(3 days ago) WebECLIPSE is a prospective registrational study to evaluate the performance of Guardant Health’s blood test in detecting signs of CRC compared to a screening …

https://www.morningstar.com/news/business-wire/20240313547689/guardant-health-eclipse-study-data-demonstrating-efficacy-of-shield-blood-based-test-for-colorectal-cancer-screening-to-be-published-in-the-new-england-journal-of-medicine

Category:  Health Show Health

Guardant Health announces positive results from pivotal ECLIPSE …

(1 days ago) WebGuardant Health announces positive results from pivotal ECLIPSE study evaluating a blood test for the detection of colorectal cancer. 3100 Hanover Street Palo …

https://guardanthealth.com/2022/12/15/guardant-health-announces-positive-results-from-pivotal-eclipse-study-evaluating-a-blood-test-for-the-detection-of-colorectal-cancer/

Category:  Cancer Show Health

Tests for Cancer Screening - GuardantHealth

(3 days ago) WebThis test has demonstrated to be accurate at detecting colorectal cancer by identifying circulating tumor DNA (ctDNA) in the blood. 20. Our ECLIPSE study validates Shield™ …

https://guardanthealth.com/products/tests-for-cancer-screening/

Category:  Cancer Show Health

Guardant Health: Positive ECLIPSE Data Signals More Upside

(8 days ago) WebOn December 15, Guardant announced highly intriguing results of its prospective study dubbed ECLIPSE (i.e., Evaluation of ctDNA LUNAR Assay In an …

https://seekingalpha.com/article/4571170-guardant-health-positive-eclipse-data-signals-more-upside

Category:  Health Show Health

Home - GuardantHealth

(2 days ago) WebECLIPSE study results published. Guardant Health is hiring bright minds in diverse fields to solve some of the most profound challenges in human health today. Learn …

https://www-.guardanthealth.com/

Category:  Health Show Health

FDA panel backs Guardant’s blood test for colon cancer - Yahoo …

(6 days ago) WebGuardant’s Eclipse study showed the Shield test had colorectal Shares of Guardant Health were rising sharply after the cancer company said a Food and Drug …

https://finance.yahoo.com/news/fda-panel-backs-guardant-blood-111122728.html

Category:  Food,  Cancer Show Health

Guardant Health Reaches Target Enrollment of 12,750 Patients in …

(7 days ago) WebGuardant Health, Inc. (Nasdaq: GH), a leading precision oncology company, announced today that it has reached its target enrollment of 12,750 patients in …

https://exchange.guardanthealth.com/2021/12/17/guardant-health-reaches-target-enrollment-of-12750-patients-in-eclipse-pivotal-study-for-its-lunar-2-blood-test-to-detect-colorectal-cancer/

Category:  Health Show Health

FDA Advisory Panel Supports Approval Of Guardant Health's …

(9 days ago) WebFDA Advisory Panel Supports Approval Of Guardant Health's Blood Test For Colorectal Cancer Screening. Benzinga. May. 24, 2024, 09:12 AM including the …

https://markets.businessinsider.com/news/stocks/fda-advisory-panel-supports-approval-of-guardant-health-s-blood-test-for-colorectal-cancer-screening-1033419799

Category:  Cancer Show Health

Guardant Health presents additional information from ECLIPSE …

(Just Now) WebGuardant Health, Inc. (Nasdaq: GH) today presented additional data from the ECLIPSE study at 2023 Digestive Disease Week (DDW) titled, “Clinical Validation of …

https://www.biospace.com/article/releases/guardant-health-presents-additional-information-from-eclipse-study-at-2023-digestive-disease-week-on-the-performance-of-shield-blood-test/

Category:  Health Show Health

Guardant Health slips as FDA comments on cancer screening test

(3 days ago) WebGuardant Health, Inc. (GH) Q4 2023 Earnings Call Transcript Guardant Health Non-GAAP EPS of -$0.46 beats by $0.27, revenue of $168.5M beats by $18.43M Guardant Health …

https://www.msn.com/en-us/health/other/guardant-health-slips-as-fda-comments-on-cancer-screening-test/ar-BB1mN1ba

Category:  Health Show Health

FDA Advisory Panel Supports Approval Of Guardant Health's

(9 days ago) WebThe panel’s recommendation is based on Guardant’s premarket approval application for Shield, including the results of the pivotal ECLIPSE study. Results …

https://www.tradingview.com/news/benzinga:4939981c5094b:0-fda-advisory-panel-supports-approval-of-guardant-health-s-blood-test-for-colorectal-cancer-screening/

Category:  Health Show Health

Guardant Health announces positive results from pivotal ECLIPSE …

(5 days ago) WebECLIPSE is a prospective registrational study to evaluate the performance of Guardant Health’s blood test in detecting signs of CRC compared to a screening …

https://www.biospace.com/article/releases/guardant-health-announces-positive-results-from-pivotal-eclipse-study-evaluating-a-blood-test-for-the-detection-of-colorectal-cancer/

Category:  Health Show Health

Filter Type: